Clostridioides difficile recurrence: Alternative microbiome-based therapies
Antibiotics disrupt the ecology of the microbiome and risk C. diff recurrence.
But what alternatives exist? In this article, discover the challenges of microbiome disease and explore the promising range of microbiome therapeutics available for recurrent CDI.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Developed by EPG Health for Medthority in collaboration with Ferring. This content is intended for healthcare professionals only, and it has been funded and reviewed by Ferring for scientific accuracy.